152 related articles for article (PubMed ID: 8249780)
1. Succimer: the first approved oral lead chelator.
Jorgensen FM
Am Fam Physician; 1993 Dec; 48(8):1496-502. PubMed ID: 8249780
[TBL] [Abstract][Full Text] [Related]
2. Management of childhood lead poisoning: a survey.
Glotzer DE; Bauchner H
Pediatrics; 1992 Apr; 89(4 Pt 1):614-8. PubMed ID: 1313555
[TBL] [Abstract][Full Text] [Related]
3. Succimer, an oral lead chelator.
Mann KV; Travers JD
Clin Pharm; 1991 Dec; 10(12):914-22. PubMed ID: 1663439
[TBL] [Abstract][Full Text] [Related]
4. Chelation therapy to treat lead toxicity in children.
Wegmann K
Minn Med; 1992 Nov; 75(11):25-7. PubMed ID: 1331737
[TBL] [Abstract][Full Text] [Related]
5. Short-term efficacy of oral dimercaptosuccinic acid in children with low to moderate lead intoxication.
Besunder JB; Anderson RL; Super DM
Pediatrics; 1995 Oct; 96(4 Pt 1):683-7. PubMed ID: 7567330
[TBL] [Abstract][Full Text] [Related]
6. Effects of calcium disodium versenate (CaNa2EDTA) chelation in moderate childhood lead poisoning.
Markowitz ME; Bijur PE; Ruff H; Rosen JF
Pediatrics; 1993 Aug; 92(2):265-71. PubMed ID: 8337028
[TBL] [Abstract][Full Text] [Related]
7. Use of orally administered succimer (meso-2,3-dimercaptosuccinic acid) for treatment of lead poisoning in dogs.
Ramsey DT; Casteel SW; Faggella AM; Chastain CB; Nunn JW; Schaeffer DJ
J Am Vet Med Assoc; 1996 Feb; 208(3):371-5. PubMed ID: 8575967
[TBL] [Abstract][Full Text] [Related]
8. Lightening the lead load in children.
Ellis MR; Kane KY
Am Fam Physician; 2000 Aug; 62(3):545-54, 559-60. PubMed ID: 10950212
[TBL] [Abstract][Full Text] [Related]
9. Use of oral dimercaptosuccinic acid (succimer) in adult patients with inorganic lead poisoning.
Bradberry S; Sheehan T; Vale A
QJM; 2009 Oct; 102(10):721-32. PubMed ID: 19700440
[TBL] [Abstract][Full Text] [Related]
10. Blood lead screening practices among US pediatricians.
Campbell JR; Schaffer SJ; Szilagyi PG; O'Connor KG; Briss P; Weitzman M
Pediatrics; 1996 Sep; 98(3 Pt 1):372-7. PubMed ID: 8784359
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of succimer chelation for reducing brain Pb levels in a rodent model.
Smith D; Bayer L; Strupp BJ
Environ Res; 1998 Aug; 78(2):168-76. PubMed ID: 9719621
[TBL] [Abstract][Full Text] [Related]
12. [Effects of chelation therapy with succimer in young rabbits of moderate lead poisoning].
Yu GY; Yan CH; Yu XG; Zuo Y; Zou XY; Xu J; Wu SH; Shen XM
Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jan; 43(1):8-13. PubMed ID: 19534872
[TBL] [Abstract][Full Text] [Related]
13. Controlled study of meso-2,3-dimercaptosuccinic acid for the management of childhood lead intoxication.
Graziano JH; Lolacono NJ; Moulton T; Mitchell ME; Slavkovich V; Zarate C
J Pediatr; 1992 Jan; 120(1):133-9. PubMed ID: 1309865
[TBL] [Abstract][Full Text] [Related]
14. The effect of succimer therapy in lead intoxication using postural balance as a measure: a case study in a nine year old child.
Bhattacharya A; Smelser DT; Berger O; Shukla R; Medvedovic M
Neurotoxicology; 1998 Feb; 19(1):57-64. PubMed ID: 9498221
[TBL] [Abstract][Full Text] [Related]
15. Succimer and the reduction of tissue lead in juvenile monkeys.
Smith DR; Woolard D; Luck ML; Laughlin NK
Toxicol Appl Pharmacol; 2000 Aug; 166(3):230-40. PubMed ID: 10906287
[TBL] [Abstract][Full Text] [Related]
16. Conceptual and practical advances in the measurement and clinical management of lead toxicity.
Graziano JH
Neurotoxicology; 1993; 14(2-3):219-23. PubMed ID: 8247395
[TBL] [Abstract][Full Text] [Related]
17. The effects of elevated blood lead levels and succimer chelation therapy on physical growth in developing rhesus monkeys.
Lasky RE; Laughlin NK; Luck ML
Environ Res; 2001 Sep; 87(1):21-30. PubMed ID: 11534961
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of succimer in toddlers with blood lead levels of 20-44 microg/dL. Treatment of Lead-Exposed Children (TLC) Trial Group.
Pediatr Res; 2000 Nov; 48(5):593-9. PubMed ID: 11044477
[TBL] [Abstract][Full Text] [Related]
19. Lead induced oxidative stress and its recovery following co-administration of melatonin or N-acetylcysteine during chelation with succimer in male rats.
Flora SJ; Pande M; Kannan GM; Mehta A
Cell Mol Biol (Noisy-le-grand); 2004; 50 Online Pub():OL543-51. PubMed ID: 15555419
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of succimer chelation for reducing brain lead in a primate model of human lead exposure.
Cremin JD; Luck ML; Laughlin NK; Smith DR
Toxicol Appl Pharmacol; 1999 Dec; 161(3):283-93. PubMed ID: 10620486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
